The polymyxin and lipopeptide classes of antibiotics are membrane-targeting drugs of last
resort used to treat infections caused by multi-drug-resistant pathogens. Despite similar …

Antimicrobial resistance is increasing in prevalence and there is a clear need for the
development of rapid detection methods in clinical diagnostics. This review explores–omics …

Methicillin-resistant Staphylococcus aureus (MRSA) is a highly dangerous pathogen, and
daptomycin has been increasingly used to treat its infections in clinics. Recently, several …

Staphylococcus aureus is a significant human pathogen known for its ability to cause a
range of infections, from minor skin conditions to life-threatening diseases. The ability of S …

Staphylococcus aureus is a gram-positive bacterium, which has developed resistance to
many antimicrobials. Methicillin-resistant S. aureus (MRSA) was first isolated in 1961. Since …

Methicillin-resistant Staphylococcus aureus (MRSA) is a serious clinical threat due to innate
virulence properties, high infection rates, and the ability to develop resistance to multiple …

Staphylococcus aureus infections pose a serious threat to human health with the increasing
incidence of microbial resistance to last-line antibiotics such as daptomycin. Many S. aureus …

It is known that bacterial populations could quickly adapt to antibiotic treatments by
becoming tolerant and resistant to the drug. Recently, adaptive laboratory evolution (ALE) …